Key facts
- It has raised $15.8M; the latest was Later Stage VC ($7.3M) in Jan 2026.
- Notable investors include Investissement Quebec, Capital Grand Est, CTI Life Sciences Fund, Domain Therapeutics, Kainova Therapeutics — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Find Therapeutics
- ·The full record, as it builds
Funding rounds
No funding rounds for Find Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Find Therapeutics
Developer of peptide-based therapies designed to treat inflammatory autoimmune diseases. The company utilizes a peptide discovery engine to design peptides that target transmembrane domains of receptors involved in key biological processes, enabling the development of next-generation treatments for autoimmune conditions.
- Sector
- Healthcare
- HQ
- Montreal, Canada
- Founded
- 2020
- Employees
- 10
- Website
- findtherapeutics.com/
- Ownership
- Privately Held (backing)
Find Therapeutics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Find Therapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Find Therapeutics in its N-PORT filings yet. We sweep new filings monthly.